OptoCeutics
OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.
About
OptoCeutics is a healthcare startup focused on treating and diagnosing neurological diseases, particularly Alzheimer's and dementia, using non-invasive light therapy. Their technology, EVY LIGHT®, utilizes 40Hz gamma wave stimulation to reconnect and strengthen neural pathways, aiming to improve cognitive function and slow disease progression. Teams look it up for Neurotechnology, Medical Devices, Healthcare.
Frequently asked
What does OptoCeutics do?
OptoCeutics is a Neurotechnology company that offers Hardware. Teams look it up for Medical Devices, Healthcare, Biotechnology. It is based in Kongens Lyngby, Denmark and was founded in 2018. Public records show about 18 people and $17M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has OptoCeutics raised?
OptoCeutics has raised a total of $17M in funding. The most recent round on record is Later Stage VC.
Where is OptoCeutics headquartered?
OptoCeutics is headquartered in Kongens Lyngby, Denmark.
When was OptoCeutics founded?
OptoCeutics was founded in 2018.
What industry does OptoCeutics operate in?
OptoCeutics operates in Neurotechnology, Medical Devices, Healthcare, Biotechnology.
How many employees does OptoCeutics have?
OptoCeutics has approximately 18 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.